Enzyme evolution and cancer: Hypothesis why natural carcinogens are more potent than synthetic ones

Life Sciences

Volumn 63, Issue 24, 1998, Pages 2141-2146

  Paolini, Moreno ^a   Biagi, Gian Luigi ^a   Bauer, Carlo ^b   Cantelli Forti, Giorgio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Cancer; Enzymes; Evolution; Metabolism; Mutations

Indexed keywords

CARCINOGEN; ENZYME;

CARCINOGENESIS; DNA REPAIR; ENZYME BINDING; ENZYME KINETICS; ENZYME METABOLISM; ENZYME SUBSTRATE COMPLEX; EVOLUTION; METABOLISM; MUTATION; NATURAL SELECTION; REVIEW;

EID: 0032491369     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00325-7     Document Type: Article

References (39)

1. 1. A.C. Knudson, Nature Genet. 5 103-105 (1993).
2. 2. A. Kamb, N.A. Gruis, J. Weaver-Feldhaus, Q. Liu, K. Harshuian, S.U. Tavtigian, E. Stokert, Rs Day III, B.E. Johnson and M.H. Skolnick, Science 264 436-440 (1994).
3. 3. F.P. Guengerich, Pharmacol. Ther. 5, 11-61 (1992).
4. 4. M. Paolini, G.L. Biagi, G. Cantelli-Forti and C. Bauer, Trends Pharmacol. Sci. 15 322-323 (1994).
5. 5. M.A. Morse and G.D. Stoner, Carcinogenesis 14 1737-1746 (1993).
6. 6. B. Vogelstein and K.W. Kinzler, Nature 355 208-209 (1992).
7. 7. B.N. Ames and L.S. Gold, Science 249 970-971 (1990).
8. 8. B.N. Ames and L.S. Gold, Science 250 1645-1646 (1990).
9. 9. F.P. Pereira, Science 250 1644 (1990).
10. 10. M. Paolini, C. Bauer, G.L. Biagi and G. Cantelli-Forti Biochem. Pharmacol. 38 2223-2225 (1989).
11. 11. M. Paolini, G.L. Biagi, C. Bauer and G. Cantelli-Forti, Biochem. Pharmacol. 42 457-458 (1991).
12. 12. D.W. Nebert, Biochem. Pharmacol. 47 25-37 (1994).
13. 13. M. Paolini and M.S. Legator, Nature 357 448 (1992).
14. 14. F.J. Gonzales and D.W. Nebert, TIG 6 182-186 (1990).
15. 15. D.W. Nebert, D.R. Nelson and R. Feyereisen, Xenobiotica 19 1149-1160 (1989).
16. 16. B.G. Hall, Proc. Natl. Acad. Sci. (USA) 89 4300-4303 (1992).
17. 17. J.A. Shapiro, Science 268 373-374 (1995).
18. 18. J. Cairns, J. Overbaugh and S. Miller, Nature 335 142-144 (1988).
19. 19. R.S. Harris, S. Longerich and S.M. Robenbrerg, Nature 264 256-260 (1994).
20. 20. J.P. Radicella, P.U. Pack and M.S. Fox, Science 268 418-420 (1995).
21. 21. T. Galitski and J.R. Roth, Science 268 4121-4123 (1995).
22. 22. J.E. Mittler and R.E. Lenski, Nature 344 173-175 (1990).
23. 23. S. Benson, BioEssays 19(1) 9-11 (1997).
24. 24. P. Sniegowski, P.J. Gerrish and R.E. Lenski, Nature 387 703-705 (1997).
25. 25. R.J. Redfield, Genetics 119 213 (1988).
26. 26. N.P. Higgins, Trends Biochem. Sci. 17 207 (1992).
27. 27. K.W. Alow, Clin. Pharmacol. Ther. 54 235-241 (1993).
28. 28. J.B.S. Haldane, Enzymes, p182, Longmans, Green and Co. (1930); M.I.T. Press (1965).
29. 28. J.B.S. Haldane, Enzymes, p182, Longmans, Green and Co. (1930); M.I.T. Press (1965).
30. 29. L. Pauling, Chem. Engng. News 24 1375-138 (1946); Am. Scient. 36 51-58 (1948).
31. 29. L. Pauling, Chem. Engng. News 24 1375-138 (1946); Am. Scient. 36 51-58 (1948).
32. 30. A. Fersht, Enzyme Structure and Mechanism, 2nd Ed., W.H. Freeman and Co. New York (1985).
33. 31. R.S. Portman, K.M. Plowman and T.C. Campbell, Biochem. Biophys. Res. Commun. 33 711-715 (1968).
34. 32. H.L. Gurtoo and T.C. Campbell, Biochem. Pharmacol. 19 1729-1735 (1970).
35. 33. H.S. Ramsdell, B. Kedzierski and D.R. Buhler, Drugs Metab. Disp. 15 32-36 (1987).
36. 34. M.A. Butler, F.P. Guengerich and F.F. Kadlubar, Cancer Res. 49 25-31 (1989).
37. 35. D.E. Williams, R.L. Reed, B. Kedzierski, G.A. Dannan, F.P. Guengerich and D.R. Buhler, Drugs Metab. Disp. 17 387-392 (1989).
38. 36. M.J. Seatom, M.M. Follamsbe and J.A. Bond, Carcinogenesis 16, 2287-2293 (1995).
39. 37. D.S. Thaller, Science 264 224-225 (1994).